QUICK TIP! Hold CTRL+F (PC) or Command+F (Mac) to search for keywords on this page.
QUICK TIP! Hold Tap (3 vertical dots. (Android) or Start typing in the URL field (iPhone) to search for keywords on this page.

Managing AKI Stage 1

Although there is no specific therapy to reverse AKI, a diligent search must be conducted for treatable causes.
AKI, acute kidney injury; HRS, hepatorenal syndrome
If AKI stage 1 is diagnosed, implement risk factor management, which includes the following:
AKI Risk Factor Management
Withdrawal of nephrotoxic drugs
Reduction of withdrawal of diuretics
Detection and treatment of infections
Volume replacement (if severely volume depleted) initially using 25% salt-poor albumin of crystalloids, preferentially balanced
Assess for one of the following scenarios:
If there is no resolution following the albumin challenge, refer to the HRS-AKI criteria below to diagnose HRS-AKI:
Cirrhosis with ascites
AKI according to the International Club of Ascites-Acute Kidney Injury criteria
No response after 2 consecutive days of diuretic withdrawal and plasma volume expansion with albumin infusion (1 g/kg body weight per day)
Absence of shock
No current or recent use of nephrotoxic drugs (NSAIDs, aminoglycosides, or iodinated contrast media)
No signs of structural kidney injury, as indicated by proteinuria (> 500 mg per day), microhematuria (> 50 red blood cells per high-power field), and/or abnormal renal ultrasonography
AKI, acute kidney injury; NSAIDs, nonsteroid anti-inflammatory drugs
Increase in SCr ≥ 0.3 mg/dL from the baseline within 48 h or a percent increase in SCr of ≥ 50%, which is known or presumed to have occurred within the preceding 7 days